Clinical Trial Update: A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update reports the first-in-human Phase 1 study of JAB-8263 in adults with advanced solid tumors, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• JAB-8263

Snippet

Sponsor: Jacobio Pharmaceuticals Co., Ltd. | Conditions: Solid Tumors, Adult | Phase 1 | Status: COMPLETED